Natco Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

36.50

36.50

36.50

36.40

36.50

Share application money

-

3.50

17.60

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

4,665.50

4,151.90

4,037.00

3,833.10

3,526.70

Loan funds

Secured loans

159.90

389.00

255.10

314.00

384.50

Unsecured loans

-

-

-

-

-

Total

4,861.90

4,580.90

4,346.20

4,183.50

3,947.70

Uses of funds

Fixed assets

Gross block

3,133.50

2,958.80

2,662.50

2,120.20

1,667.00

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

899.70

784.60

656.60

545.70

452.10

Net block

2,233.80

2,174.20

2,005.90

1,574.50

1,214.90

Capital work-in-progress

62.80

128.70

223.40

517.80

637.50

Investments

657.50

550.00

337.00

191.10

244.40

Net current assets

Current assets, loans & advances

2,433.80

2,125.10

2,186.20

2,363.30

2,259.30

Less : current liabilities & provisions

526.00

397.10

406.30

463.20

408.40

Total net current assets

1,907.80

1,728.00

1,779.90

1,900.10

1,850.90

Miscellaneous expenses not written

-

-

-

-

-

Total

4,861.90

4,580.90

4,346.20

4,183.50

3,947.70

Notes:

Book value of unquoted investments

126.60

84.10

68.00

39.50

139.90

Market value of quoted investments

98.90

121.10

119.80

56.20

6.80

Contingent liabilities

55.00

52.30

42.80

98.80

78.10

Number of equity sharesoutstanding (Lacs)

1825.20

1825.20

1823.38

1820.68

1827.46